gefitinib has been researched along with zinc oxide in 1 studies
| Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (zinc oxide) | Trials (zinc oxide) | Recent Studies (post-2010) (zinc oxide) |
|---|---|---|---|---|---|
| 5,231 | 566 | 2,919 | 8,874 | 262 | 6,485 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, X; Liu, Z; Wang, J; Xu, Y; Yang, Y; Zhang, Y; Zhao, Z | 1 |
1 other study(ies) available for gefitinib and zinc oxide
| Article | Year |
|---|---|
Novel β-1,3-d-glucan porous microcapsule enveloped folate-functionalized liposomes as a Trojan horse for facilitated oral tumor-targeted co-delivery of chemotherapeutic drugs and quantum dots.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Biological Transport; Cell Survival; Chitosan; Drug Compounding; Drug Liberation; Drug Synergism; Fluorescent Dyes; Folic Acid; Gefitinib; Humans; Liposomes; Male; Mice; Mice, Nude; Mouth Neoplasms; Porosity; Proteoglycans; Quantum Dots; Rats, Sprague-Dawley; Tissue Distribution; Zinc Oxide | 2020 |